Coronavirus (COVID-19): visiting The Royal Marsden suspended

Due to the increasing numbers of cases of coronavirus across the UK, we have suspended all visiting to The Royal Marsden apart from specific circumstances. Read here for more information.

Cervical cancer prevention week 2020

Cervical screening offers the greatest protection against cervical cancer with smear tests preventing 75% of cervical cancers but the number of women attending cervical screening in the UK is falling. 

20 January 2020

  • Early diagnosis is key to improving survival from cancer
  • The NHS has calculated that we can save 55,000 additional lives every year by diagnosing cancers early
  • When cancer is diagnosed at an early stage, there is a much greater chance of being able to treat it successfully – often with less invasive procedures and fewer long-term side effects

John Butler, Consultant Gynaecological Oncology Surgeon said:

"Cervical screening can find changes and high risk human papillomavirus (HPV) early, before it develops into cancer and last year saw the introduction of a HPV vaccine for both girls and boys being rolled out in schools across the country.  If cervical screening attendance increases and with the introduction of the HPV vaccine, within the next 10 years, we will see a noticeable drop in cervical cancer rates and improved survival.”

"Between 2016 and 2018 we saw nearly 800 cervical cancer patients at The Royal Marsden. Scientific advances in gynaecological cancer have increased our understanding of the subtypes of cancers, which has led to better targeted treatments for these patients with the latest surgical and radiotherapy equipment available."

When found early, cervical cancer is highly treatable and associated with high survival rates so raising awareness of symptoms, encouraging cervical screening attendance and noticing any changes which are unusual for you and your body is vital.

John Butler, Consultant Gynaecological Oncology Surgeon
  • Between 2016 – 2018 we’ve seen nearly 800 cervical cancer patients
  • The Royal Marsden is a centre of excellence for gynaecological cancers, offering a specialist research led service for the staging and treatment of ovarian, cervical, endometrial, vaginal and vulval cancers.
  • Our Gynaecology Unit is made up of a multidisciplinary team of experts who treat patients using the latest techniques and technologies in diagnostics, surgery, chemotherapy and radiotherapy.

Dr Nicholas van As, Medical Director at The Royal Marsden said:

"Diagnosing cancer early is crucial to improving patient outcomes. Our GP Education Programme is one of the ways we support our primary care colleagues, giving them access to our consultants and researchers who provide the very latest updates on the signs and symptoms of cancer."